0001140361-18-011724.txt : 20180302 0001140361-18-011724.hdr.sgml : 20180302 20180302172329 ACCESSION NUMBER: 0001140361-18-011724 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170628 FILED AS OF DATE: 20180302 DATE AS OF CHANGE: 20180302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FILDES FRANCIS CENTRAL INDEX KEY: 0001661786 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37977 FILM NUMBER: 18663398 MAIL ADDRESS: STREET 1: 10-1 BLANCHARDSTOWN CORPORATE PARK STREET 2: BALLYCOOLIN CITY: DUBLIN STATE: L2 ZIP: 15 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001012477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK STREET 2: BALLYCOOLIN CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 636-449-1830 MAIL ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE ROAD STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 FORMER COMPANY: FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA DATE OF NAME CHANGE: 19960422 4/A 1 doc1.xml FORM 4/A X0306 4/A 2017-06-28 2017-06-30 0 0001012477 AVADEL PHARMACEUTICALS PLC AVDL 0001661786 FILDES FRANCIS BLOCK 10-1, BLANCHARDSTOWN CORPORATE PARK, BALLYCOOLIN DUBLIN L2 15 IRELAND 1 0 0 0 Stock Option (right to buy) 10.51 2017-06-28 4 A 0 35000 10.51 A 2018-06-28 2022-06-28 ADSs 35000 35000 D Options become exercisable as to all 35,000 ADSs on the first anniversary of the 06/28/2017 grant date. The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts. This amendment to the Form 4 filed by the reporting person on June 30, 2017 (the "Previous Form 4") is being filed solely to correct the number of derivative securities acquired and the number of derivative securities beneficially owned following the transaction reported in Columns 5 and 9 of Table II of the Previous Form 4. The number of derivative securities in the Previous Form 4 was incorrectly listed as 30,000 and has been corrected to 35,000. /s/ Phillandas T. Thompson, as attorney-in-fact for Francis Fildes 2018-03-02